SAB Biotherapeutics Inc. Gains 41.56%
Tue, Apr 18, 2023 at 07:10 PM
SAB Biotherapeutics Inc. (SABS:NASDAQ) soared at $1.09, representing a gain of 41.6%. On Tue, Apr 18, 2023, SABS:NASDAQ touched a New 2-Week High of $1.09. The stock got featured on our News Catalysts scanner on Tue, Apr 18, 2023 at 09:12 AM in the 'BIOTECH' category. From Tue, Apr 04, 2023, the stock recorded 33.33% Up Days and 50.00% Green Days
The stock spiked on Tue, Apr 18, 2023 at $1.45 with a volume of 37M+.
About SAB Biotherapeutics Inc. (SABS:NASDAQ)
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company advancing a class of immunotherapies based on its human polyclonal antibodies.
Top 10 Gainers:
- BELLUS Health Inc. (BLU:NASDAQ), 98.9%
- Agrify Corporation (AGFY:NASDAQ), 73.91%
- Oblong Inc. (OBLG:NASDAQ), 61.21%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 60.13%
- Super League Gaming, Inc. (SLGG:NASDAQ), 54.44%
- Gamida Cell Ltd. (GMDA:NASDAQ), 50.89%
- Glory Star New Media Group Holdings Limited (GSMG:NASDAQ), 47.92%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 44.98%
- Petros Pharmaceuticals Inc. (PTPI:NASDAQ), 42.49%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 41.56%